While Chen Xia was still arranging to open a textile factory, several subsequent papers were published in The Lancet.
Especially for the latest research on asthma treatment.
Changing the method of using hormones from oral and intravenous administration to nebulized inhalation, which has fewer side effects, lower hormone content and better efficacy, this innovative treatment plan immediately attracted the attention of doctors around the world.
It's good that clinicians are taking notice.
What bad intentions could doctors have? They just want more clinical drugs, better patient care, and to demonstrate their medical prowess.
Besides, the medicine is not used for free. No matter which pharmaceutical company representative comes, you have to pay "hardship fee" or "lecture fee" or something like that.
However, the paper also attracted strong attention from several international pharmaceutical giants, and these capital giants are not so simple.
A duck knows first when the river water warms in spring. When the Hong Kong Pumpkin Vine Company was selecting partners for the several drugs used in the quadruple therapy, it only chose the three largest pharmaceutical companies in each continent.
These include Pfizer in the United States, GlaxoSmithKline in Europe, and Takeda Pharmaceutical in Japan. These three companies are basically in the leading position.
But this leader only means that the company has the largest scale and the greatest influence. However, there are still many powerful pharmaceutical companies in the world that have their own flagship products and monopoly drugs.
For example, the American company "Li Lai Pharmaceutical"
In the United States, it is a pharmaceutical giant second only to Pfizer and Johnson & Johnson. Of course, their flagship products are mainly insulin and some biological agents.
These products have high technological content. For example, biological agents are not only used to treat tumors, but also have obvious advantages in treating rheumatoid arthritis that no traditional drugs have.
Because of its monopoly position, drug prices are set very high, and profits are high. This also leads to Lilly's ambition to always want to defeat Pfizer and become the boss.
After obtaining patents for new drugs such as omeprazole and clarithromycin, Pfizer Pharmaceuticals made a fortune in the American digestive disease drug market, making all other companies jealous.
Later, "Sildenafil" was born.
Before anyone could react, it was snatched away by GlaxoSmithKline. The two companies set up a wholly-owned subsidiary to produce the product themselves, and everyone could only watch this huge cake.
Now a series of nebulized inhalation drugs and anti-allergic drugs have come out, which has instantly made all pharmaceutical companies sensitive and they immediately called together the company's expert team to conduct paper research.
The results of the study are very positive. If the drug is effective, it will be a groundbreaking and revolutionary drug in asthma and allergic diseases.
Asthma and allergic diseases are common diseases. Because they are common, more people use medications. Sales are high and profits are high, so you don’t even need to calculate. Just think about how big the cake will be.
If nothing unexpected happens, the profit will even exceed that of omeprazole.
This is different from drugs for rare diseases. Although drugs for rare diseases are expensive, costing tens of thousands or even millions of yuan per dose, few people use them.
The reason is that there are few patients with rare diseases, and the key is that the drugs are expensive and not everyone can afford them, so the profit is actually just that.
If it weren't for government subsidies, the research and production of many drugs for rare diseases would be unsustainable.
Just like the simplest one, everyone has heard of snake venom serum, which is the only life-saving medicine at critical moments.
However, few people use snake venom serum. Manufacturers are unwilling to produce it, and hospitals are unwilling to purchase it. If it expires, you are the one who suffers the loss.
This also leads to many patients being sent to several hospitals after being bitten by snakes, because most domestic hospitals do not have snake venom serum.
Other drugs, such as those for amyotrophic lateral sclerosis (ALS), Crohn's disease, multiple sclerosis, pulmonary hypertension, hemophilia, and cancer, are both expensive and rare.
Although these drugs for rare diseases are expensive, the profit margins are actually not high, and many may not even be able to recoup the research and development costs.
The top management of Lilai Pharmaceuticals reached a consensus. In view of the previous reliability of Xiangjiang Pumpkin Vine Company and the fact that all of its latest developed drugs were blockbuster hits, they also wanted to get involved.
The chairman of the company is Paulk, an old man in his 70s. To become a corporate giant in the United States, one must be a fox with a thousand years of experience.
In a capitalist society, people will do anything to achieve their goals, no matter if it means cheating, stealing or anything else, as long as they can get these drugs.
At the closed-door board meeting, Paulk knocked on the table and said in a deep voice:
"Our company must send someone to the International Medical Forum being held in China this time. If we can obtain patent authorization from Xiangjiang Pumpkin Vine Company, that would be great. If not, we'll try to get a few of their drugs back."
Bring back some medicine? What for?
Everyone in the office knew that there were a lot of copied medicines in the world, so it seemed that the old fox had no good intentions.
President Swift was a bit troubled: "Chairman, the problem is that we didn't receive an invitation. What should we do?"
"I'll take care of the invitation. The Mayo Clinic has received the invitation this time. I'll have their Vice Chairman, Childe Steve, arrange for you to join their delegation. Swift, you'll go to China in person this time."
"Okay, Chairman."
The same meeting was held at different pharmaceutical companies. The difference was that some companies really wanted to cooperate, while some companies, such as Lilai Pharmaceuticals, had more complicated purposes.
Yes, some companies have a very simple idea: if you don’t cooperate with me, I will just copy your medicine this time. At most, I can just make some minor changes to it.
What? You want to sue me? Go ahead.
The judicial procedures in European and American countries are extremely complicated. The courts alone are divided into many levels, such as state courts, federal courts, circuit courts, the Supreme Court, etc. It may take several years for a lawsuit to reach a conclusion after going through each level.
It will all come down to who can outlast the other. How can a small Hong Kong company like you compete with the financial might of a pharmaceutical giant? You'll be killed by these delays.
This is something they have tried and tested before, and it has proven to be very effective without any failure.
The road to capital has always been bloody.
Chen Xia didn't know the little thoughts of the pharmaceutical giants from various countries, and it wouldn't matter even if he knew. After all, he had ways to "harm others without benefiting himself."
Even if there is no way out in the end, it is not a big deal for Pumpkin Vine Pharmaceutical Company. There are so many medicines in the space hospital, so what if there is one more or one less?
He is no longer worried about whether his medicine can make money happily.
What bothered him was that his hospital was facing medical disputes, and the people involved were a group of people with strong backgrounds.
Yuezhou Iron and Steel Plant, the largest enterprise in Yuezhou area, is a large enterprise with 20,000 employees. Their employees came to the People's Hospital to cause trouble. If this is not handled properly, the consequences will be serious.
Continue read on readnovelmtl.com